SYnAbs SA
PrivateLast Round
Grant
Dec 1, 2022
Total Funding Raised
$630,000
Company Overview
SYnAbs SA is a biotechnology company that specializes in the development and production of innovative monoclonal antibodies for research, diagnostic, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SYnAbs SA Comparables
Compare SYnAbs SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Creative Biolabs | 85% | |
| Precision Antibody | 82% | |
| BIOTEM | 81% | |
SYnAbs SA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2022 | ||||
| Grant | Mar 19, 2021 | ||||
| Seed | Sep 14, 2015 |
SYnAbs SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Biotech Investissement | Seed |
| Université catholique de Louvain | Seed |
| Walloon Region (Belgium) | Grant |
SYnAbs SA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SYnAbs SA's valuation, stock price, and market status.